These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10499560)

  • 1. Efficacy and safety of spirapril in mild-to-moderate hypertension.
    Hayduk K; Kraul H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
    Noble S; Sorkin EM
    Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
    van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute hemodynamic, hormonal, and pharmacokinetic properties of oral spirapril in patients with moderate to severe heart failure.
    van den Broek SA; van Bruggen A; de Graeff PA; Hillege H; van Gilst WH; Wesseling H; Lie KI
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):614-21. PubMed ID: 1724540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.
    Guitard C; Lohmann FW; Alfiero R; Ruina M; Alvisi V
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
    Fairhurst GJ
    Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW
    Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC; White CM
    Clin Pharmacokinet; 2002; 41(3):207-24. PubMed ID: 11929321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease.
    Krähenbühl S; Grass P; Surve A; Kutz K; Reichen J
    Eur J Clin Pharmacol; 1993; 45(3):247-53. PubMed ID: 8276049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirapril: pharmacokinetic properties and drug interactions.
    Grass P; Gerbeau C; Kutz K
    Blood Press Suppl; 1994; 2():7-13. PubMed ID: 8061850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cough induced activity of spirapril in rats.
    Kamei J; Hitosugi H; Kasuya Y
    Gen Pharmacol; 1993 Nov; 24(6):1443-5. PubMed ID: 8112517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.